Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10442854 Neutralizing anti-influenza binding molecules and uses thereof

Patent 10442854 was granted and assigned to MedImmune on October, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
MedImmune
MedImmune
0
Date Filed
May 31, 2016
0
Date of Patent
October 15, 2019
0
Patent Applicant
MedImmune
MedImmune
0
Patent Application Number
15577799
0
Patent Citations Received
‌
US Patent 11932682 Neutralizing anti-influenza A antibodies and uses thereof
0
‌
US Patent 11524993 Neutralizing anti-influenza binding molecules and uses thereof
‌
US Patent 11547756 Method of treating influenza A
‌
US Patent 10882897 Neutralizing anti-influenza binding molecules and uses thereof
‌
US Patent 11787853 Neutralizing anti-influenza b antibodies and uses thereof
‌
US Patent 11926657 Neutralizing anti-influenza binding molecules and uses thereof
0
Patent Inventor Names
Qing Zhu
0
Cuihua Gao
0
Godfrey Jonah Rainey
0
Nicole Kallewaard-Lelay
0
Changshou Gao
0
Srinath Kasturirangan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10442854
0
Patent Primary Examiner
‌
Shanon A. Foley
0

Find more entities like US Patent 10442854 Neutralizing anti-influenza binding molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.